Selected research
Industry Growth & Trends
Global Drugs Produced by Fermentation Engineering Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Drugs Produced by Fermentation Engineering market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Drugs Produced by Fermentation Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Drugs Produced by Fermentation Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Drugs Produced by Fermentation Engineering is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Drugs Produced by Fermentation Engineering market include Changchun GeneScience Pharmaceutical, Tonghua Dongbao Pharmaceutical, Sichuan Kelun Pharmaceutical, CSPC Pharmaceutical Group, Shanghai Shyndec Pharmaceutical, Shanghai Fosun Pharmaceutical, 3SBio Inc, United Laboratories International Holdings and Shandong Kexing Bioproducts, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Drugs Produced by Fermentation Engineering market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Drugs Produced by Fermentation Engineering market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drugs Produced by Fermentation Engineering market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drugs Produced by Fermentation Engineering.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Drugs Produced by Fermentation Engineering market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Drugs Produced by Fermentation Engineering Market by Company
Changchun GeneScience Pharmaceutical
Tonghua Dongbao Pharmaceutical
Sichuan Kelun Pharmaceutical
CSPC Pharmaceutical Group
Shanghai Shyndec Pharmaceutical
Shanghai Fosun Pharmaceutical
3SBio Inc
United Laboratories International Holdings
Shandong Kexing Bioproducts
Joincare Pharmaceutical Group
North China Pharma
Harbin Pharmaceutical Group
Gan and Lee Pharmaceuticals
Anhui Anke Biotechnology
Drugs Produced by Fermentation Engineering Segment by Type
Monoclonal Antibodies
Antibiotic
Human Growth Hormone
Pharmaceutical Amino Acids
Insulin
Others
Drugs Produced by Fermentation Engineering Segment by Application
Hospital
Clinic
Other
Drugs Produced by Fermentation Engineering Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs Produced by Fermentation Engineering market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs Produced by Fermentation Engineering and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs Produced by Fermentation Engineering.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Drugs Produced by Fermentation Engineering companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Monoclonal Antibodies
- Antibiotic
- Human Growth Hormone
- Pharmaceutical Amino Acids
- Insulin
- Others
Applications
- Hospital
- Clinic
- Other
Companies covered
- Changchun GeneScience Pharmaceutical
- Tonghua Dongbao Pharmaceutical
- Sichuan Kelun Pharmaceutical
- CSPC Pharmaceutical Group
- Shanghai Shyndec Pharmaceutical
- Shanghai Fosun Pharmaceutical
- 3SBio Inc
- United Laboratories International Holdings
- Shandong Kexing Bioproducts
- Joincare Pharmaceutical Group
- North China Pharma
- Harbin Pharmaceutical Group
- Gan and Lee Pharmaceuticals
- Anhui Anke Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Drugs Produced by Fermentation Engineering Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Drugs Produced by Fermentation Engineering Market Size by Region (2021-2032)
- 1.4.1 Global Drugs Produced by Fermentation Engineering Market Size by Region (2021-2026)
- 1.4.2 Global Drugs Produced by Fermentation Engineering Market Size by Region (2027-2032)
- 1.5 Key Regions Drugs Produced by Fermentation Engineering Market Size (2021-2032)
- 1.5.1 North America Drugs Produced by Fermentation Engineering Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Drugs Produced by Fermentation Engineering Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Drugs Produced by Fermentation Engineering Market Size Growth Rate (2021-2032)
- 1.5.4 South America Drugs Produced by Fermentation Engineering Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Drugs Produced by Fermentation Engineering Market Size Growth Rate (2021-2032)
2 Drugs Produced by Fermentation Engineering Market by Type
- 2.1 Type Introduction
- 2.1.1 Monoclonal Antibodies
- 2.1.2 Antibiotic
- 2.1.3 Human Growth Hormone
- 2.1.4 Pharmaceutical Amino Acids
- 2.1.5 Insulin
- 2.1.6 Others
- 2.2 Global Drugs Produced by Fermentation Engineering Market Size by Type
- 2.2.1 Global Drugs Produced by Fermentation Engineering Market Size Overview by Type (2021-2032)
- 2.2.2 Global Drugs Produced by Fermentation Engineering Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Drugs Produced by Fermentation Engineering Market Size Forecasted by Type (2027-2032)
- 2.3 Global Drugs Produced by Fermentation Engineering Market Size by Regions
- 2.3.1 North America Drugs Produced by Fermentation Engineering Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Drugs Produced by Fermentation Engineering Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Drugs Produced by Fermentation Engineering Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Drugs Produced by Fermentation Engineering Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Drugs Produced by Fermentation Engineering Market Size Breakdown by Type (2021-2026)
3 Drugs Produced by Fermentation Engineering Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.1.3 Other
- 3.2 Global Drugs Produced by Fermentation Engineering Market Size by Application
- 3.2.1 Global Drugs Produced by Fermentation Engineering Market Size Overview by Application (2021-2032)
- 3.2.2 Global Drugs Produced by Fermentation Engineering Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Drugs Produced by Fermentation Engineering Market Size Forecasted by Application (2027-2032)
- 3.3 Global Drugs Produced by Fermentation Engineering Market Size by Regions
- 3.3.1 North America Drugs Produced by Fermentation Engineering Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Drugs Produced by Fermentation Engineering Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Drugs Produced by Fermentation Engineering Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Drugs Produced by Fermentation Engineering Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Drugs Produced by Fermentation Engineering Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Drugs Produced by Fermentation Engineering Industry Trends
- 4.2 Drugs Produced by Fermentation Engineering Industry Drivers
- 4.3 Drugs Produced by Fermentation Engineering Industry Opportunities and Challenges
- 4.4 Drugs Produced by Fermentation Engineering Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Drugs Produced by Fermentation Engineering Revenue (2021-2026)
- 5.2 Global Drugs Produced by Fermentation Engineering Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Drugs Produced by Fermentation Engineering Key Company Headquarters & Area Served
- 5.4 Global Drugs Produced by Fermentation Engineering Company, Product Type & Application
- 5.5 Global Drugs Produced by Fermentation Engineering Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Drugs Produced by Fermentation Engineering Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Drugs Produced by Fermentation Engineering Players Market Share by Revenue in 2025
- 5.6.3 2025 Drugs Produced by Fermentation Engineering Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Changchun GeneScience Pharmaceutical
- 6.1.1 Changchun GeneScience Pharmaceutical Company Information
- 6.1.2 Changchun GeneScience Pharmaceutical Business Overview
- 6.1.3 Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Changchun GeneScience Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
- 6.1.5 Changchun GeneScience Pharmaceutical Recent Developments
- 6.2 Tonghua Dongbao Pharmaceutical
- 6.2.1 Tonghua Dongbao Pharmaceutical Company Information
- 6.2.2 Tonghua Dongbao Pharmaceutical Business Overview
- 6.2.3 Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Tonghua Dongbao Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
- 6.2.5 Tonghua Dongbao Pharmaceutical Recent Developments
- 6.3 Sichuan Kelun Pharmaceutical
- 6.3.1 Sichuan Kelun Pharmaceutical Company Information
- 6.3.2 Sichuan Kelun Pharmaceutical Business Overview
- 6.3.3 Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Sichuan Kelun Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
- 6.3.5 Sichuan Kelun Pharmaceutical Recent Developments
- 6.4 CSPC Pharmaceutical Group
- 6.4.1 CSPC Pharmaceutical Group Company Information
- 6.4.2 CSPC Pharmaceutical Group Business Overview
- 6.4.3 CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 CSPC Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio
- 6.4.5 CSPC Pharmaceutical Group Recent Developments
- 6.5 Shanghai Shyndec Pharmaceutical
- 6.5.1 Shanghai Shyndec Pharmaceutical Company Information
- 6.5.2 Shanghai Shyndec Pharmaceutical Business Overview
- 6.5.3 Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Shanghai Shyndec Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
- 6.5.5 Shanghai Shyndec Pharmaceutical Recent Developments
- 6.6 Shanghai Fosun Pharmaceutical
- 6.6.1 Shanghai Fosun Pharmaceutical Company Information
- 6.6.2 Shanghai Fosun Pharmaceutical Business Overview
- 6.6.3 Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Shanghai Fosun Pharmaceutical Drugs Produced by Fermentation Engineering Product Portfolio
- 6.6.5 Shanghai Fosun Pharmaceutical Recent Developments
- 6.7 3SBio Inc
- 6.7.1 3SBio Inc Company Information
- 6.7.2 3SBio Inc Business Overview
- 6.7.3 3SBio Inc Drugs Produced by Fermentation Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 3SBio Inc Drugs Produced by Fermentation Engineering Product Portfolio
- 6.7.5 3SBio Inc Recent Developments
- 6.8 United Laboratories International Holdings
- 6.8.1 United Laboratories International Holdings Company Information
- 6.8.2 United Laboratories International Holdings Business Overview
- 6.8.3 United Laboratories International Holdings Drugs Produced by Fermentation Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 United Laboratories International Holdings Drugs Produced by Fermentation Engineering Product Portfolio
- 6.8.5 United Laboratories International Holdings Recent Developments
- 6.9 Shandong Kexing Bioproducts
- 6.9.1 Shandong Kexing Bioproducts Company Information
- 6.9.2 Shandong Kexing Bioproducts Business Overview
- 6.9.3 Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Shandong Kexing Bioproducts Drugs Produced by Fermentation Engineering Product Portfolio
- 6.9.5 Shandong Kexing Bioproducts Recent Developments
- 6.10 Joincare Pharmaceutical Group
- 6.10.1 Joincare Pharmaceutical Group Company Information
- 6.10.2 Joincare Pharmaceutical Group Business Overview
- 6.10.3 Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Joincare Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio
- 6.10.5 Joincare Pharmaceutical Group Recent Developments
- 6.11 North China Pharma
- 6.11.1 North China Pharma Company Information
- 6.11.2 North China Pharma Business Overview
- 6.11.3 North China Pharma Drugs Produced by Fermentation Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 North China Pharma Drugs Produced by Fermentation Engineering Product Portfolio
- 6.11.5 North China Pharma Recent Developments
- 6.12 Harbin Pharmaceutical Group
- 6.12.1 Harbin Pharmaceutical Group Company Information
- 6.12.2 Harbin Pharmaceutical Group Business Overview
- 6.12.3 Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Harbin Pharmaceutical Group Drugs Produced by Fermentation Engineering Product Portfolio
- 6.12.5 Harbin Pharmaceutical Group Recent Developments
- 6.13 Gan and Lee Pharmaceuticals
- 6.13.1 Gan and Lee Pharmaceuticals Company Information
- 6.13.2 Gan and Lee Pharmaceuticals Business Overview
- 6.13.3 Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Gan and Lee Pharmaceuticals Drugs Produced by Fermentation Engineering Product Portfolio
- 6.13.5 Gan and Lee Pharmaceuticals Recent Developments
- 6.14 Anhui Anke Biotechnology
- 6.14.1 Anhui Anke Biotechnology Company Information
- 6.14.2 Anhui Anke Biotechnology Business Overview
- 6.14.3 Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Anhui Anke Biotechnology Drugs Produced by Fermentation Engineering Product Portfolio
- 6.14.5 Anhui Anke Biotechnology Recent Developments
7 North America
- 7.1 North America Drugs Produced by Fermentation Engineering Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Drugs Produced by Fermentation Engineering Market Size by Country (2021-2026)
- 7.3 North America Drugs Produced by Fermentation Engineering Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Drugs Produced by Fermentation Engineering Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Drugs Produced by Fermentation Engineering Market Size by Country (2021-2026)
- 8.3 Europe Drugs Produced by Fermentation Engineering Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Drugs Produced by Fermentation Engineering Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Drugs Produced by Fermentation Engineering Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Drugs Produced by Fermentation Engineering Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Drugs Produced by Fermentation Engineering Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Drugs Produced by Fermentation Engineering Market Size by Country (2021-2026)
- 10.3 South America Drugs Produced by Fermentation Engineering Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Drugs Produced by Fermentation Engineering Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Drugs Produced by Fermentation Engineering Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Drugs Produced by Fermentation Engineering Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst